4//SEC Filing
Jantzen Beth 4
Accession 0001104659-20-069841
CIK 0000744452other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:32 PM ET
Size
5.5 KB
Accession
0001104659-20-069841
Insider Transaction Report
Form 4
Jantzen Beth
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2020-06-03+6,965→ 6,965 totalExercise: $8.36Exp: 2030-06-02→ Common Stock (6,965 underlying)
Footnotes (1)
- [F1]The options vest immediately.
Documents
Issuer
APPLIED DNA SCIENCES INC
CIK 0000744452
Entity typeother
Related Parties
1- filerCIK 0001633940
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:32 PM ET
- Size
- 5.5 KB